SHS Gesellschaft fur Beteiligungsmanagement invested an undisclosed amount in CoreMedic, a heart valve-repair startup based in Switzerland and Germany. The capital will support continued development of CoreMedic's ChordArt technologies as the company looks to advance a first-in-human clinical use of its product for next year and launch a clinical trial to support European approval.
CoreMedic secures capital for heart-valve repair technologies
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.